Related Articles
Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma
Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck
Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo
A novel approach to glioma therapy using an oncolytic adenovirus with two specific promoters
A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Δ24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy